<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OCC-11001394</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2011-06-09</date_registration>
      <primary_sponsor>The first clinical hosptial  of Harb Medical University</primary_sponsor>
      <public_title>Study on the effect of Hepatitis B virus on haemopoietic stem cell</public_title>
      <acronym />
      <scientific_title>Study on the effect of Hepatitis B virus on haemopoietic stem cell</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2010-07-01</date_enrolment>
      <type_enrolment />
      <target_size>group1:20;group2:20;group3:20;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=8145</url>
      <study_type>Observational study</study_type>
      <study_design>Case-Control study</study_design>
      <phase>Other</phase>
      <hc_freetext>Chronic hepatitis B</hc_freetext>
      <i_freetext>group1:cord blood come from healthy control delivery woma;group2:cord blood come from HBsAg+,HBeAg+delivery woman;group3:Chronic hepatitis B volunteers bone marrow  ;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Qin Yan</firstname>
        <middlename />
        <lastname />
        <address>Department of infectious diseases, The First clinical hospital, Harbin Medical University, 26 Youzheng Road, Nangang District, Harbin, China</address>
        <city />
        <country1 />
        <zip>150001</zip>
        <telephone>+86 13503630411</telephone>
        <email>yanqinqin@hotmail.com</email>
        <affiliation>Department of infectious diseases, The First clinical hospital, Harbin Medical University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yongguo Li</firstname>
        <middlename />
        <lastname />
        <address>Department of infectious diseases, The First clinical hospital, Harbin Medical University, 26 Youzheng Road, Nangang District, Harbin, China</address>
        <city />
        <country1 />
        <zip>150001</zip>
        <telephone>+86 0451 85555197</telephone>
        <email>liyongguo@54dr.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1 HBsAg+, HBeAg+delivery women;
2 healthy delivery women;chronic hepatitis B patients;
3. healthy volunteers</inclusion_criteria>
      <agemin>0</agemin>
      <agemax>0</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. HBsAg+, HBeAg+delivery women who have chronic or acute hepatitis C; 
2. Healthy delivery women who have other acute hepatitis and the blood system diseases; 
3. Chronic hepatitis B volunteers who have chronic hepatitis C.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Stem cell come from cord blood of HBsAg+, HBeAg+delivery women whether or not infected by HBV;Stem cell come from cord blood of healthy contol group whether or not infected HBV in vitro;Immune function of stem cell come from Chronic hepatitis B volunteers bone marrow;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Chinese National Natural Science Foundation</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2011-04-24</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>